Reilly RT - Search Results

1

Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?

Reilly RT, Emens LA, Jaffee EM. Reilly RT, et al. Curr Opin Investig Drugs. 2001 Jan;2(1):133-5. Curr Opin Investig Drugs. 2001. PMID: 11527005 Review.

2

Augmenting the potency of breast cancer vaccines: combined modality immunotherapy.

Emens LA, Reilly RT, Jaffee EM. Emens LA, et al. Among authors: reilly rt. Breast Dis. 2004;20:13-24. doi: 10.3233/bd-2004-20103. Breast Dis. 2004. PMID: 15687703 Review.

3

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM. Reilly RT, et al. Cancer Res. 2001 Feb 1;61(3):880-3. Cancer Res. 2001. PMID: 11221874

4

Chemotherapy: friend or foe to cancer vaccines?

Emens LA, Machiels JP, Reilly RT, Jaffee EM. Emens LA, et al. Among authors: reilly rt. Curr Opin Mol Ther. 2001 Feb;3(1):77-84. Curr Opin Mol Ther. 2001. PMID: 11249735 Review.

5

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Machiels JP, et al. Among authors: reilly rt. Cancer Res. 2001 May 1;61(9):3689-97. Cancer Res. 2001. PMID: 11325840

6

Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.

Emens LA, Reilly RT, Jaffee EM. Emens LA, et al. Among authors: reilly rt. Endocr Relat Cancer. 2005 Mar;12(1):1-17. doi: 10.1677/erc.1.00671. Endocr Relat Cancer. 2005. PMID: 15788636 Review.

7

A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.

Emens LA, Armstrong D, Biedrzycki B, Davidson N, Davis-Sproul J, Fetting J, Jaffee E, Onners B, Piantadosi S, Reilly RT, Stearns V, Tartakovsky I, Visvanathan K, Wolff A. Emens LA, et al. Among authors: reilly rt. Hum Gene Ther. 2004 Mar;15(3):313-37. doi: 10.1089/104303404322886165. Hum Gene Ther. 2004. PMID: 15018740 No abstract available.

8

Cytokine gene-modified cell-based cancer vaccines.

Reilly RT, Machiels JP, Emens LA, Jaffee EM. Reilly RT, et al. Methods Mol Med. 2002;69:233-57. doi: 10.1385/1-59259-141-8:233. Methods Mol Med. 2002. PMID: 11987781 Review. No abstract available.

9

Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice.

Ercolini AM, Machiels JP, Chen YC, Slansky JE, Giedlen M, Reilly RT, Jaffee EM. Ercolini AM, et al. Among authors: reilly rt. J Immunol. 2003 Apr 15;170(8):4273-80. doi: 10.4049/jimmunol.170.8.4273. J Immunol. 2003. PMID: 12682262

10

HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice.

Wolpoe ME, Lutz ER, Ercolini AM, Murata S, Ivie SE, Garrett ES, Emens LA, Jaffee EM, Reilly RT. Wolpoe ME, et al. Among authors: reilly rt. J Immunol. 2003 Aug 15;171(4):2161-9. doi: 10.4049/jimmunol.171.4.2161. J Immunol. 2003. PMID: 12902523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters